Total Payments
$3,015
2024 Payments
$137.40
Companies
16
Transactions
59
Medicare Patients
10,778
Medicare Billing
$1.8M
Payment Breakdown by Category
Food & Beverage$1,460 (48.4%)
Other$1,000.00 (33.2%)
Travel$549.68 (18.2%)
Education$5.00 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,460 | 55 | 48.4% |
| Honoraria | $1,000 | 1 | 33.2% |
| Travel and Lodging | $549.68 | 2 | 18.2% |
| Education | $5.00 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $1,242 | 6 | $0 (2023) |
| Pacira Pharmaceuticals Incorporated | $653.25 | 4 | $0 (2023) |
| ABBVIE INC. | $351.87 | 26 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $201.44 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $147.19 | 3 | $0 (2022) |
| Aurinia Pharma U.S., Inc. | $113.40 | 1 | $0 (2023) |
| Janssen Biotech, Inc. | $62.30 | 3 | $0 (2023) |
| UCB, Inc. | $48.93 | 2 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $40.94 | 2 | $0 (2021) |
| PFIZER INC. | $35.38 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $137.40 | 1 | Novartis Pharmaceuticals Corporation ($137.40) |
| 2023 | $379.07 | 7 | Horizon Therapeutics plc ($224.47) |
| 2022 | $960.81 | 19 | Pacira Pharmaceuticals Incorporated ($635.72) |
| 2021 | $168.84 | 12 | AbbVie Inc. ($127.08) |
| 2020 | $1,125 | 8 | Horizon Therapeutics plc ($1,000) |
| 2019 | $243.38 | 12 | AbbVie, Inc. ($55.80) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $137.40 | General |
| Category: Dermatology | ||||||
| 10/09/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: KRYSTEXXA | ||||||
| 05/05/2023 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Pain Management | ||||||
| 04/20/2023 | Aurinia Pharma U.S., Inc. | — | Food and Beverage | In-kind items and services | $113.40 | General |
| 03/27/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: KRYSTEXXA | ||||||
| 03/27/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $2.10 | General |
| Category: KRYSTEXXA | ||||||
| 03/22/2023 | Horizon Therapeutics plc | — | Food and Beverage | In-kind items and services | $195.30 | General |
| 02/23/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Immunology | ||||||
| 12/01/2022 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $123.97 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 10/28/2022 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Travel and Lodging | In-kind items and services | $137.07 | General |
| Category: Pain Management | ||||||
| 10/18/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $33.80 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2022 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $86.04 | General |
| Category: Pain Management | ||||||
| 10/07/2022 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Travel and Lodging | In-kind items and services | $412.61 | General |
| Category: Pain Management | ||||||
| 10/06/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Immunology | ||||||
| 09/08/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.07 | General |
| Category: IMMUNOLOGY | ||||||
| 07/21/2022 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: Endocrinology | ||||||
| 07/14/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.51 | General |
| Category: IMMUNOLOGY | ||||||
| 07/14/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $0.38 | General |
| Category: IMMUNOLOGY | ||||||
| 07/11/2022 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Education | In-kind items and services | $5.00 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 05/12/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: IMMUNOLOGY | ||||||
| 05/03/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: IMMUNOLOGY | ||||||
| 04/12/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: KRYSTEXXA | ||||||
| 04/01/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: IMMUNOLOGY | ||||||
| 04/01/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.42 | General |
| Category: IMMUNOLOGY | ||||||
| 04/01/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.35 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 54 | 3,545 | 23,750 | $1.8M | $441,218 |
| 2022 | 51 | 3,079 | 21,351 | $1.7M | $475,092 |
| 2021 | 40 | 2,175 | 24,015 | $2.0M | $380,376 |
| 2020 | 42 | 1,979 | 35,601 | $2.6M | $501,675 |
Total Patients
10,778
Total Services
104,717
Medicare Billing
$1.8M
Procedure Codes
187
All Medicare Procedures & Services
187 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 88 | 6,180 | $376,980 | $112,977 | 30.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 385 | 820 | $248,460 | $82,010 | 33.0% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 20 | 5,670 | $175,770 | $45,411 | 25.8% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 12 | 2,950 | $135,700 | $30,653 | 22.6% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 13 | 820 | $82,820 | $21,275 | 25.7% |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | Office | 2023 | 11 | 590 | $89,680 | $15,863 | 17.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 106 | 106 | $62,646 | $13,960 | 22.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 150 | 170 | $35,360 | $13,025 | 36.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 61 | 96 | $82,464 | $11,329 | 13.7% |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | Office | 2023 | 18 | 2,125 | $91,375 | $10,493 | 11.5% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 92 | 139 | $52,681 | $9,307 | 17.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 36 | 57 | $21,033 | $7,823 | 37.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 160 | 160 | $48,480 | $6,999 | 14.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 51 | 88 | $26,378 | $5,877 | 22.3% |
| 86235 | Measurement of antibody for assessment of autoimmune disorder, any method | Office | 2023 | 40 | 273 | $16,107 | $4,516 | 28.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 248 | 396 | $16,236 | $4,043 | 24.9% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2023 | 63 | 126 | $13,860 | $3,895 | 28.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 284 | 461 | $5,071 | $3,811 | 75.2% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 48 | 96 | $11,712 | $3,522 | 30.1% |
| 82306 | Vitamin d-3 level | Office | 2023 | 119 | 121 | $11,616 | $3,487 | 30.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 38 | 40 | $11,520 | $2,998 | 26.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $9,334 | $2,245 | 24.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 180 | 291 | $9,021 | $2,187 | 24.2% |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | Office | 2023 | 44 | 44 | $7,216 | $1,908 | 26.4% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 34 | 39 | $7,878 | $1,905 | 24.2% |
About Dr. Katherine Maher, M.D
Dr. Katherine Maher, M.D is a Rheumatology healthcare provider based in Frederick, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2010. The National Provider Identifier (NPI) number assigned to this provider is 1225353865.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Katherine Maher, M.D has received a total of $3,015 in payments from pharmaceutical and medical device companies, with $137.40 received in 2024. These payments were reported across 59 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,460).
As a Medicare-enrolled provider, Maher has provided services to 10,778 Medicare beneficiaries, totaling 104,717 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 187 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Frederick, MD
- Active Since 04/06/2010
- Last Updated 02/16/2022
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1225353865
Products in Payments
- KRYSTEXXA (Biological) $1,046
- Iovera (Device) $653.25
- RINVOQ (Biological) $252.56
- SAPHNELO (Biological) $147.19
- COSENTYX (Drug) $137.40
- Cimzia (Drug) $48.93
- COSENTYX (Biological) $44.04
- TREMFYA (Drug) $41.61
- ORENCIA (Biological) $40.94
- RINVOQ (Drug) $34.54
- UPTRAVI (Drug) $31.19
- Tymlos (Biological) $26.63
- Rinvoq (Biological) $22.69
- GENERAL PAIN MANAGEMENT (Device) $22.11
- SIMPONI ARIA (Biological) $20.69
- Humira (Biological) $20.28
- ILARIS (Biological) $20.00
- INFLECTRA (Biological) $17.91
- XELJANZ (Drug) $17.47
- RENFLEXIS (Biological) $16.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.